MRC1 and colorectal carcinoma: This possibly contributes to their elimination by the local immune surveillance43 and may explain the limited penetrance of Lynch syndrome, with only 50% life-time CRC risk, despite the presence of thousands of MMR-deficient crypt foci in Lynch syndrome mutation carriers.24